Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone and Ropivacaine for Post-Craniotomy Pain
NCT04078139Phase 4Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylprednisolone in postoperative pain, sponsored by Beijing Tiantan Hospital. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04078139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078139.